Influenza HA (518-526) is an H-2Kd-restricted epitope of the influenza virus hemagglutinin comprised amino acids 533 to 541.
Influenza HA 518-526 is a synthetic peptide corresponding to a conserved epitope within the hemagglutinin (HA) protein of the influenza virus. As a segment derived from the HA protein, it plays a pivotal role in the study of viral entry mechanisms, antigenic profiling, and immune recognition. Its defined sequence and high specificity make it a valuable research tool for dissecting the molecular interactions between influenza viruses and host cells, as well as for advancing understanding of antigenic determinants relevant to influenza pathogenesis and immunity.
Epitope mapping: The peptide is widely employed in epitope mapping studies to delineate the precise regions of the HA protein that are recognized by antibodies or T cell receptors. Through in vitro assays such as ELISA or peptide microarrays, researchers can use the 518-526 sequence to identify immunodominant epitopes, thereby enhancing the characterization of the humoral and cellular immune responses to influenza infection or vaccination. This application provides essential insights into the mechanisms of immune recognition and supports the rational design of next-generation vaccines.
Immunological assays: As a defined linear epitope, the HA 518-526 peptide is routinely used in immunological assays to assess T cell reactivity and specificity. It serves as a model antigen in ex vivo stimulation experiments, such as ELISpot or intracellular cytokine staining, to quantify and characterize antigen-specific T cell populations in human or animal samples. This enables detailed profiling of immune memory and effector functions, facilitating studies of immune correlates of protection and the evaluation of vaccine-induced responses.
Structural and binding studies: The sequence is instrumental in structural biology investigations aimed at elucidating the molecular basis of HA-antibody or HA-receptor interactions. By employing the peptide in binding assays, surface plasmon resonance, or co-crystallization experiments, researchers can define the structural determinants of antigen-antibody recognition or receptor engagement. These findings inform the development of broadly neutralizing antibodies and contribute to the understanding of viral escape mechanisms.
Peptide-based vaccine research: The HA 518-526 fragment is frequently utilized in preclinical research focused on the design and evaluation of peptide-based immunogens. Its inclusion in synthetic vaccine constructs allows for targeted stimulation of immune responses against conserved regions of the influenza virus, supporting the exploration of epitope-focused vaccination strategies. Such studies are essential for advancing approaches that aim to elicit cross-protective immunity against diverse influenza strains.
Quality control and analytical standards: The defined properties of the peptide make it a reliable standard for quality control in peptide synthesis and analytical method validation. Laboratories use the HA 518-526 sequence to calibrate mass spectrometry, HPLC, or other analytical platforms, ensuring the accuracy and reproducibility of peptide identification and quantification. This application underpins the rigorous characterization of peptide reagents and supports the standardization of experimental protocols across influenza research laboratories.
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More